Cash flow Ion Beam Applications, SA
Equities
IBAB
BE0003766806
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.12 EUR | -0.15% |
|
-2.67% | -2.24% |
Feb. 06 | IBA Signs Proteus One System Contract With AIG In India | RE |
Jan. 21 | IBA, Wallonie Entreprendre Invest in German Startup | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 7.61M | 31.92M | 3.88M | 6.06M | -9.11M | |||||
Depreciation & Amortization - CF | 3.03M | 8.78M | 8.37M | 8.99M | 9.77M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 763K | 1.46M | - | 327K | 250K | |||||
Depreciation & Amortization, Total | 3.8M | 10.24M | 8.37M | 9.32M | 10.02M | |||||
Amortization of Deferred Charges, Total - (CF) | 2.81M | 1.72M | 1.52M | 1.4M | 1.5M | |||||
(Gain) Loss From Sale Of Asset | -15.3M | - | - | - | - | |||||
(Gain) Loss on Sale of Investments - (CF) | -1.06M | -547K | 704K | -3.59M | 654K | |||||
Asset Writedown & Restructuring Costs | 6.14M | - | - | - | - | |||||
(Income) Loss On Equity Investments - (CF) | 1.12M | 3.23M | 1.25M | -3K | 169K | |||||
Stock-Based Compensation (CF) | - | 130K | 800K | 9M | 1M | |||||
Provision and Write-off of Bad Debts | -503K | 2.9M | -287K | -749K | 457K | |||||
Net Cash From Discontinued Operations | - | - | - | - | - | |||||
Other Operating Activities, Total | 4.07M | 1.85M | -8.27M | -25.83M | -5.94M | |||||
Change In Accounts Receivable | -21.75M | 20.79M | 29.36M | -73M | 3.72M | |||||
Change In Inventories | 65.65M | 26.06M | 48.04M | 66.01M | -53.16M | |||||
Change In Accounts Payable | 2.87M | 2.16M | 16.18M | 40.72M | 11.35M | |||||
Change in Other Net Operating Assets | -6.84M | -24K | -14.34M | -7.62M | 19.56M | |||||
Cash from Operations | 48.62M | 100M | 87.21M | 21.71M | -19.77M | |||||
Capital Expenditure | -4.58M | -2.56M | -4.24M | -3.23M | -5.26M | |||||
Sale of Property, Plant, and Equipment | 2.01M | - | 33K | - | - | |||||
Cash Acquisitions | - | - | - | -8.68M | -270K | |||||
Divestitures | 12.49M | - | 1.27M | - | - | |||||
Sale (Purchase) of Intangible assets | -541K | -1.45M | -784K | -4.1M | -7.05M | |||||
Investment in Marketable and Equity Securities, Total | -6.1M | -1.6M | -4.42M | -3.09M | - | |||||
Net (Increase) Decrease in Loans Originated / Sold - Investing | - | - | - | - | - | |||||
Other Investing Activities, Total | -1.52M | - | 115K | -36K | -740K | |||||
Cash from Investing | 1.75M | -5.6M | -8.02M | -19.14M | -13.32M | |||||
Long-Term Debt Issued, Total | 9M | 25.51M | - | - | - | |||||
Total Debt Issued | 9M | 25.51M | - | - | - | |||||
Long-Term Debt Repaid, Total | -50.12M | -9.99M | -18.13M | -30.81M | -7.49M | |||||
Total Debt Repaid | -50.12M | -9.99M | -18.13M | -30.81M | -7.49M | |||||
Issuance of Common Stock | 131K | 2.09M | 977K | 176K | 115K | |||||
Repurchase of Common Stock | - | - | -11.23M | -5.16M | - | |||||
Common Dividends Paid | - | -2.25M | -5.78M | -5.58M | -6.12M | |||||
Common & Preferred Stock Dividends Paid | - | -2.25M | -5.78M | -5.58M | -6.12M | |||||
Special Dividend Paid | - | - | - | - | - | |||||
Other Financing Activities, Total | -1.38M | -1.99M | -2.12M | -105K | -889K | |||||
Cash from Financing | -42.37M | 13.37M | -36.28M | -41.48M | -14.38M | |||||
Foreign Exchange Rate Adjustments | -609K | -371K | 2.45M | -2M | -1.58M | |||||
Net Change in Cash | 7.39M | 108M | 45.36M | -40.9M | -49.06M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 2.81M | 2.3M | 2.69M | 2.31M | 761K | |||||
Cash Income Tax Paid (Refund) | 1.94M | 1.13M | 1.8M | 4.42M | 2.52M | |||||
Levered Free Cash Flow | 52.82M | 67.89M | 122M | 24.16M | -20.1M | |||||
Unlevered Free Cash Flow | 54.37M | 69.63M | 123M | 25.45M | -19.27M | |||||
Change In Net Working Capital | -53.14M | -35.42M | -109M | -15.22M | 23.19M | |||||
Net Debt Issued / Repaid | -41.12M | 15.52M | -18.13M | -30.81M | -7.49M |